Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Apoptosis in Adriamycin Cardiomyopathy and Its Modulation by Probucol
2001
Heart Failure Epidemiology and Novel Treatments in Japan: Facts and Numbers
2016
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Oxidative Stress and Antioxidant Defense
2012 Standout
The effect of melatonin on bleomycin‐induced pulmonary fibrosis in rats
2002
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Imaging microvascular obstruction and its clinical significance following acute myocardial infarction
2006
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
Free radicals, antioxidants and functional foods: Impact on human health
2010 Standout
Oxidative stress, aging, and diseases
2018 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis
1999
Coronary microvascular dysfunction in the clinical setting: from mystery to reality
2012
Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase
2005
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Production of cytokines in patients infected by hepatitis C virus
1998
A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure
2012
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Retrieval and analysis of particulate debris after saphenous vein graft intervention
1999
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Significance of Melatonin in Antioxidative Defense System: Reactions and Products
2000
Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants
2001
Purkinje‐Related Arrhythmias Part I: Monomorphic Ventricular Tachycardias
2011
Role of oxidative stress in cardiovascular diseases
2000
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies
2005
A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction
2006
Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of ?no reflow? phenomenon
2000
Cardiovascular Magnetic Resonance in Patients With Myocardial Infarction
2009
Protective Effects of Angiotensin II Interruption: Evidence for Antiinflammatory Actions
2005
Intracoronary verapamil for reversal of no‐reflow during coronary angioplasty for acute myocardial infarction
2002
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Sickle-cell disease
2010 Standout
Regulation of antioxidant enzymes: a significant role for melatonin
2003 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart
2003
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
2007 Standout
Doxorubicin-Induced Cardiomyopathy
2007
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
2008 Standout
Myocardial Reperfusion Injury
2007 Standout
Myocarditis
2000 Standout
Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse
1998
Third Universal Definition of Myocardial Infarction
2012 Standout
CD39 and CD73 in immunity and inflammation
2013 Standout
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin
2009
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
2006
Cardiac safety of liposomal anthracyclines
2004
No-reflow phenomenon and prognosis in patients with acute myocardial infarction
2006
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
2012
Nicardipine and adenosine “flush cocktail” to prevent no-reflow during rotational atherectomy
2008
One molecule, many derivatives: A never‐ending interaction of melatonin with reactive oxygen and nitrogen species?
2006 Standout
Effects of physiological and pharmacological concentrations of melatonin on ischemia–reperfusion arrhythmias in rats: can the incidence of sudden cardiac death be reduced?
2002
Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicine
2008 Standout
Human viral cardiomyopathy
2003
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
2020
Erythropoietin Pretreatment Protects Against Acute Chemotherapy Toxicity in Isolated Rat Hearts
2008
National Survey of Fulminant Myocarditis in Japan
2002
Myocarditis
2006 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin
2002
Drug-Induced Oxidative Stress and Toxicity
2012
Beneficial Effects of Intracoronary Adenosine as an Adjunct to Primary Angioplasty in Acute Myocardial Infarction
2000
Guidelines for the Primary Prevention of Stroke
2014 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Polycyclic Polyprenylated Acylphloroglucinols
2006 Standout
First-line drugs for hypertension
2018
Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing
2007 Standout
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Sickle cell disease and stroke
2009
Schisandra chinensis protects against adriamycin-induced cardiotoxicity in rats.
2006
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Receptors for Purines and Pyrimidines
2012 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Resuscitation From Fulminant Myocarditis Associated With Refractory Ventricular Fibrillation
2000
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Cytochrome P450 2C19 Polymorphism, Suboptimal Reperfusion and All-Cause Mortality in Patients with Acute Myocardial Infarction
2010
Spontaneous coronary artery dissection
2017
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
Protective effects of melatonin on myocardial ischemia-reperfusion induced infarct size and oxidative changes.
2005
Synthesis and Biological Evaluation of Hyperforin Analogues. Part I. Modification of the Enolized Cyclohexanedione Moiety
2002
Works of Itsuro Morishima being referenced
Acute myocardial infarction caused by spontaneous postpartum coronary artery dissection
2007
Zinc accumulation in adriamycin‐induced cardiomyopathy in rats: Effects of melatonin, a cardioprotective antioxidant
1999
Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy and Apical Aneurysm
2018
Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease
2003
A case of fulminant myocarditis rescued: By long-term percutaneous cardiopulmonary support.
1994
Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats
1998
Verapamil-sensitive left anterior fascicular ventricular tachycardia associated with a healed myocardial infarction: changes in the delayed Purkinje potential during sinus rhythm
2008
Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction
2000
Renal Protective Effects and the Prevention of Contrast-Induced Nephropathy by Atrial Natriuretic Peptide
2009
Serum Levels of Soluble Interleukin-2 Receptor in Chronic Hepatitis C Treated with Interferon-Alpha
1995
Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury
2000
Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats
1999
Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty
1995
916-86 Percutaneous Cardiopulmonary Bypass Support (PCPS) for the Treatment of Acute Fulminant Myocarditis Unresponsive to Maximum Medical Therapy
1995